Aventis Pharma Q3 PAT up at Rs 105cr

Aventis Pharma Q3 net profit was up 304% at Rs 105 crore versus Rs 26 crore, year-on-year, YoY.

Its net sales were up at Rs 286 crore versus Rs 237 crore, YoY.


Source: www.moneycontrol.com

Thanks,
Gaurav Agarwal
Head Dealer
DENIP Consultants Pvt Ltd